Is Scopolamine Transdermal System in shortage?
Scopolamine Transdermal System is listed by FDA as being discontinued by at least one maker (updated Nov 3, 2025).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)
Discontinuation of the manufacture of the drug
Maker contact: 866-634-9120
FDA recalls of Scopolamine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Scopolamine Transdermal System:
- Mckesson Medical-Surgical Inc. Corporate Office recalls Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only,
- L. Perrigo Company recalls Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46);
Scopolamine Transdermal System shortage questions
Is Scopolamine Transdermal System in shortage?
Scopolamine Transdermal System is listed by FDA as being discontinued by at least one maker (updated Nov 3, 2025).
What should I do if I can’t get Scopolamine Transdermal System?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.